CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase

Leukemia
M HuangL M Graves

Abstract

Cyclopentenyl cytosine (CPEC) is a carbocyclic cytidine analog inhibitor of CTP synthetase and experimental drug for combination chemotherapy. CPEC treatment (50 nM) depleted intracellular CTP and induced a specific S-phase arrest and erythroid differentiation of human erythroleukemia K562 cells. The equilibrative nucleoside transporters (ENT1, 2) facilitated uptake of CPEC into K562 cells as evidenced by both NBMPR and dipyridamole inhibition of CPEC-mediated CTP depletion and erythroid differentiation. Incubation with the pyridinylimidazole p38 MAPK inhibitors, SB203580 or SB220025, suppressed both the CPEC-induced cell cycle arrest and differentiation of K562 cells. SB203580 also prevented the cell cycle arrest and erythroid differentiation of K562 cells induced by Leflunomide (LEF), a non-nucleoside inhibitor of the de novo pyrimidine pathway, without affecting LEF-induced depletion of pyrimidine pools. Finally, selective knockdown of p38 MAPK by using Smart Pooltrade mark siRNA to p38 MAPK significantly decreased the CPEC-induced differentiation of K562 cells. These results suggest that endogenous activity of p38 MAP kinases may be required for committing K562 cells to cell cycle arrest and erythroid differentiation under ...Continue Reading

References

Jan 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R J SlingerlandA B Van Kuilenburg
Apr 6, 1993·Biochemical Pharmacology·S M BlaneyD G Poplack
Sep 12, 1998·The Journal of Biological Chemistry·T Morooka, E Nishida
Nov 21, 1998·The Journal of Biological Chemistry·J A EngelmanP E Scherer
May 14, 1999·Molecular Medicine Today·S A BaldwinJ D Young
Feb 17, 2000·Cellular Signalling·K Ono, J Han
Mar 30, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A C VerschuurA B Van Kuilenburg
Feb 21, 2002·Molecular Pharmacology·Min HuangLee M Graves
Feb 22, 2002·The Journal of Biological Chemistry·Heather A FoleyBetty S Pace
Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Arnauld C VerschuurAndré B P Van Kuilenburg
Jun 22, 2002·The Journal of Biological Chemistry·Min HuangLee M Graves
Dec 10, 2002·International Journal of Cancer. Journal International Du Cancer·Jörgen BierauAndré B P Van Kuilenburg
Dec 17, 2002·Cancer Treatment and Research·Marilyn L ClarkeCarol E Cass
Jan 1, 2003·American Journal of Hematology·Kanoko SawafujiYasuo Ikeda
Jan 23, 2003·The Journal of Pharmacology and Experimental Therapeutics·Min HuangLee M Graves
Oct 31, 2003·Experimental Hematology·Betty S PaceStuart D Critz

❮ Previous
Next ❯

Citations

Nov 27, 2010·Cancer Chemotherapy and Pharmacology·Anna FyrbergKourosh Lotfi
Jun 19, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·G Berkovitch-LuriaZ Malik
Jan 25, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Karin Hoppe-SeylerFelix Hoppe-Seyler
Jul 25, 2009·British Journal of Pharmacology·M Sztiller-SikorskaM Czyz
Sep 28, 2005·Biochemical Pharmacology·Malgorzata CzyzMarkus Düchler
Aug 23, 2012·Biochemical and Biophysical Research Communications·A FyrbergK Lotfi
May 29, 2014·Molecular Pharmaceutics·María Ángela AznarMaria J Blanco-Prieto
Aug 7, 2009·Experimental Biology and Medicine·Tzu-Fang LouBetty S Pace

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.